Three murine plasmacytomas that were exceptional in lacking the characteristic (12;15) or (6;15) translocations were studied by G banding and high-resolution banding. One of every two chromosomes 15 (two of four in tetraploid tumors) was shortened in all three tumors. High-resolution banding analysis revealed that this was due to an interstitial deletion in the 15D band region. The two breaks responsi-
strain of mice consistently contain one of two alternative translocations, rcpt (12;15) or rcpt(6;15) (1, 2). rcpt (12;15) is referred to as the typical translocation because it is found in the majority of the murine plasmacytomas, including both K and X chain producers. The variant rcpt(6;15) is only seen in a minority of the K chain producers. Chromosomes 12 and 6 are known to carry the Ig heavy chain and the K light chain locus, respectively (3) (4) (5) . Therefore, we have suggested (2) that the translocations contribute to the carcinogenic process by transposing an oncogene, located in the distal segment of chromosome 15, into the highly active neighborhood of the immunoglobulin genes (6) . This hypothesis was further supported by closely similar findings on a human B-cellderived tumor, Burkitt lymphoma (for review see ref. 6 ). Molecular analysis of tumors containing the typical translocations has confirmed this hypothesis and also showed that the two systems are homologous, because they involve the same oncogene, c-myc. In the mouse, the c-myc is located at the translocation breakpoint on chromosome 15. In the majority of the cases it is transposed to the Sa,-C, region of the IgH locus on chromosome 12, where it is actively transcribed (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) .
Pristane oil-induced plasmacytomas show a great preponderance of the rcpt(12;15) translocation (==85%). Plasmacytomas induced by a combination of pristane oil and Abelson murine leukemia virus (A-MuLV) carry (12;15) and (6;15) in approximately equal proportions (17) . In our previous study on 14 pristane oil-induced early-passage generation plasmacytomas, we have encountered 2 tumors that did not contain any translocations (1) . In another karyotypic study of 8 diffusion chamber-and 17 A-MuLVinduced plasmacytomas, 1 and 2 tumors were translocation negative, respectively (unpublished data).
In a total of 39 murine plasmacytomas we have thus encountered 5 translocation-negative tumors (13%). Although some of them were near diploid and others near tetraploid, they appeared to lack any obvious chromosomal marker. The question arose whether they had been generated by different mechanisms.
We now report that G-banding studies on three translocation-negative tumors, combined with high-resolution banding (HRB) analysis, revealed the same type of aberrant banding pattern in three tumors affecting part of the major D band. We previously found (1, 2) that the breakpoint on chromosome 15, involved in the plasmacytoma-associated rcpt(12;15) and rcptW';15) translocations, can be localized to the same band.
MATERIALS AND METHODS
Plasmacytomas. ABPC26 and ABPC45 were induced in BALB/c mice by injecting 0.5 ml of pristane oil intraperitoneally and infecting the mice intraperitoneally with 0.1 ml of A-MuLV 23-56 days later. CBPC112 was induced by 0.5 ml of pristane oil intraperitoneally as described in ref 1. Chromosome Preparation. Metaphase plates were prepared from the ascites of plasmacytomas without Colcemid treatment. G banding was performed by a slight modification of Wang and Federoffs method (18) . Chromosomes were identified according to the standard mouse karyotype (19) .
HRB. High quality prometaphase and prophase chromosome plates were prepared according to the method of Yu et al. (20) adapted to mouse chromosomes. Major and minor band identification followed the nomenclature of Nesbitt and Francke (21) .
Isolation and Hybridization of RNA and DNA Blots. Genomic DNAs were prepared, digested with restriction endonuclease, electrophoresed in 0.7% agarose gels, transferred to nitrocellulose filters, and hybridized as described (22) . Total poly(A)+ RNA was prepared, electrophoresed in 1% agarose gels containing 5 mM methylmercury hydroxide, transferred to 2-aminophenylthioether (APT) paper, and hybridized as described (22) . In both cases, the hybridization probe was a nick-translated 5.5-kilobase-pair BamHI fragment excised from a plasmid containing c-myc from plasmacytoma S107 (14) . Table 1 summarizes the main immunoglobulin and karyotype characteristics of the three translocation-negative plasmacytomas. More detailed karyotypes will be reported elsewhere (unpublished data).
RESULTS
Abbreviations: A-MuLV, Abelson murine leukemia virus; HRB, high-resolution banding.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Conventional G banding showed no detectable changes in chromosome 6, 12, or 15. However, detailed analysis of some plates with well-preserved and elongated chromosomes focused our attention on a regular size difference between the two chromosomes 15. Diploid tumor cells usually contained one chromosome 15 that was shorter than its normal homologue (Fig. 1) , whereas tetraploid tumor cells contained two shortened and two normal chromosomes 15 (Fig.  2) . The difference in length could be related to a size difference in the major band 15D.
To obtain more precise information, we have analyzed the pairs of chromosome 15 by HRB in two plasmacytomas, ABPC26 and ABPC45. Fig. 3 shows the findings in ABPC26. In the normal chromosome 15, the major D band is composed of two minor dark bands (D1 and D3) of approximately equal size. A minor white band (D2), thinner than D1 and D3, is intercalated between the dark bands. In contrast, the aberrant chromosome 15 contained only one thin D band, corresponding in size to either the D1 or D3 band. There was no intercalated white band visible at all. This was more easily recognizable on the chromosome pairs subjected to HRB analysis (Fig. 3 a-c) than on the conventional G-banded chromosomes (Fig. 3 d-f) . We interpret these findings to mean that an interstitial deletion has occurred in these tumors, resulting in a smaller D band and a correspondingly shorter chromosome 15.
Southern blots of EcoRI, BamHI, and HindIII digests of genomic DNAs were hybridized to a c-myc probe (Fig. 4a) was also indicated by the RNA transfer blots (Fig. 4b) . Only the normal-sized 2.4-kilobase myc RNA was present in all three tumors, including ABPC45 ( Table 2 ). The intensity of the RNA band suggested a 3-to 10-fold increased level of the c-myc transcription product, compared to normal spleen cell RNA, and a 2-to 3-fold increase over normal thymus RNA. DISCUSSION Using HRB, we have found (23) that the breakpoint on chromosome 15 in plasmacytomas with the typical (12;15) or the variant (6;15) translocation maps to the junction (interface) between bands D2 and D3. Molecular studies have shown (9, 11, 16 ) that the break usually cuts across the 5' end exon of the c-myc gene or its immediate neighborhood, and the severed oncogene is translocated to the immunoglobulin heavy chain locus (IgH). Frequently, it faces the a switch region immediately 5' to the IgA heavy chain constant region, although occasionally it may face other regions. In all of these cases, the c-myc and IgH sequences face each other head to head, 5' to 5' (9)-i.e., in the reverse transcriptional orientation.
In the present study, three translocation-negative plasmacytomas were analyzed. In each of these tumors, one of the two homologous chromosomes 15 (or two offour in the tetra- The cytogenetic mapping of the breakpoints flanking the deleted segment is determined by the orientation of the cmyc locus in relation to the centromere. As drawn schematically in Fig. 5 , the 5' end of c-myc gene on chromosome 15 could be centromere proximal (alternative A) or distal (alternative B).
According to alternative A, the first break would occur outside the 5' exon of the oncogene through the interface of bands D2/3. This would be consistent with the normal-sized c-myc transcripts and also with the previously defined breakpoint on chromosome 15 in translocation-carrying plasmacytomas. Because HRB has revealed that the minor white D2 band was deleted, the second break-proximal to centromere-has to occur either on the interface of bands D2/1 or within the D1 band (Fig. Sa) . This would suggest that the dark band on the deleted chromosome 15 arose from the joining of the D3 band-the c-myc-carrying chromosomal re- gion-with the D1 band or part of the latter (Fig. Sb) .
The other possibility is illustrated in alternative B. Here, the same two assumptions are made: the first break occurs Twenty-five micrograms of genomic DNA was digested with the restriction endonuclease indicated, electrophoresed on a 0.7% agarose gel, blotted onto nitrocellulose, and hybridized as described (22) . (b) Five micrograms of poly(A)+ RNA was denatured and electrophoresed on 1% agarose gels containing 5 mM methylmercury hydroxide, blotted onto diazotized paper, and hybridized as described (22) . Sizes are given in kilobases.
just outside the 5' exon of c-myc gene and affects band D2/3. It represents the centromere-proximal break in this case. The second break would occur distally to the first, on the telomeric side (Fig. 5c) It has been suggested that the deletion of the 5' exon of cmyc or the translocation of the oncogene to an active Ig region (or both) may be responsible for the constitutive switchon of the oncogene. The existence of the "deletion" plasmacytomas shows that the gene can also be activated by rearrangement within a single chromosome 15. It is most likely that this happens by the joining of the 5' end of the cmyc oncogene to an actively transcribed chromatin region in the D1 band area of chromosome 15.
